[18] Secondary deficiencies can occur in people who consume adequate amounts, but have malabsorption conditions, such as cystic fibrosis or chronic pancreatitis, and in people who have liver damage or disease
Table of Contents The Drug That Kept Becoming Something Else The Joint Surprise Liver and Alcohol Why Tirzepatide and Not Pure GLP-1 This Is the Bet I am Making Why Not Retatrutide What It Has Done for Me Safety Concerns Micronutrients References The Drug That Kept Becoming Something Else When John Eng found GLP-1 in the saliva of the Gila monster in the early 1990s, all it was supposed to do was lower blood sugar
Lo-Carb Monster Energy
Gentle, Low-Dose Approach Designed to work in sync with your bodyminimizing side effects while supporting long-term wellness
Topf is an assistant clinical professor of medicine at Oakland University William Beaumont School of Medicine, creator and host of the Freely Filtered and Channel Your Enthusiasm podcasts, creator of the Precious Bodily Fluids blog, and co-creator of NephMadness and NephJC
Patent Policy Priorities for Young Adult Patients: An Agenda for Drug Affordability and Competition at the USPTO Our patient community depends on medications that can cost hundreds of thousands of dollars a year, and the patent system directly shapes whether they can afford the treatments they need to survive
